Perioperative physical exercise interventions for patients undergoing lung cancer surgery: What is the evidence?

Abstract

Surgical resection appears to be the most effective treatment for early-stage non-small cell lung cancer. Recent studies suggest that perioperative pulmonary rehabilitation improves functional capacity, reduces mortality and postoperative complications and enhances recovery and quality of life in operated patients. Our aim is to analyse and identify the most recent evidence-based physical exercise interventions, performed before or after surgery. We searched in MEDLINE, EMBASE, CINAHL, Cochrane Library and PsycINFO. We included randomised controlled trials aimed at assessing efficacy of exercise-training programmes; physical therapy interventions had to be described in detail in order to be reproducible. Characteristics of studies and programmes, results and outcome data were extracted. Six studies were included, one describing preoperative rehabilitation and three assessing postoperative intervention. It seems that the best preoperative physical therapy training should include aerobic and strength training with a duration of 2–4 weeks. Although results showed improvement in exercise performance after preoperative pulmonary rehabilitation, it was not possible to identify the best preoperative intervention due to paucity of clinical trials in this area. Physical training programmes differed in every postoperative study with conflicting results, so comparison is difficult. Current literature shows inconsistent results regarding preoperative or postoperative physical exercise in patients undergoing lung resection. Even though few randomised trials were retrieved, treatment protocols were difficult to compare due to variability in design and implementation. Further studies with larger samples and better methodological quality are urgently needed to assess efficacy of both preoperative and postoperative exercise programmes.

Introduction

Lung cancer is the leading cause of cancer death in males, and in females, its mortality burden is as high as cervical cancer.¹ In 2012, an estimated 1.8 million people were diagnosed with lung cancer, resulting in 1.6 million deaths.² Lung cancer is the leading malignant cause of death in 93 countries, accounting for one-fifth of the total global burden of disability-adjusted life years from cancer.² Non-small cell lung cancer (NSCLC)² comprises 85% of all lung cancers. Up to 63% of patients diagnosed with lung cancer also present chronic obstructive pulmonary disease (COPD).³ If we consider all stages of NSCLC, the prognosis is poor, with an overall 5-year survival rate of 15%.⁴ Lobectomy for initial stages demonstrates higher survival rates, but only 15%−25% of patients are surgical candidates because of cardiopulmonary impairment due to coexisting COPD. Therefore, patients undergo medical treatment or marginal lung resection, with minor functional impact but possible ineffective control of disease.^5–7 Furthermore, coexisting COPD is associated with increased postoperative morbidity and mortality.^5,6

Improvements in early diagnosis and surgical techniques have increased post-surgery survival rates. Therefore, in recent years, there has been a growing interest towards interventions that aim at improving health-related quality of life (HRQoL) and lessening morbidity for patients affected by lung cancer, either before or after surgery.^8,9

‘Pulmonary Rehabilitation (PR) is a comprehensive intervention based on a thorough patient assessment followed by patient-tailored therapies, that include, but are not limited to, exercise training, education and behaviour change designed to improve physical and psychological condition of people with chronic respiratory disease and to promote the long-term adherence to health-enhancing behaviours’.¹⁰ PR goals include minimising symptom burden, maximising exercise performance, promoting autonomy, increasing participation in everyday activities, enriching HRQoL and influencing long-term health-enhancing behaviour change.^7,10 It is widely recognised that physical exercise is the cornerstone in PR programmes.¹¹

It has been shown that preoperative PR ameliorates functional parameters that establish operability in COPD patients; therefore, candidates for surgery could benefit from this functional improvement in terms of larger possible lung resection and lower incidence of postoperative complications.^7,11

Recent guidelines by Spruit et al.¹⁰ highlight findings of uncontrolled trials reporting that PR after lung resection surgery improves walking endurance and peak exercise capacity, while reducing dyspnoea and fatigue. Likewise, postoperative PR significantly improves respiratory function and exercise capacity in treated patients, but the effect on long-term functioning and HRQoL is still under debate.^10,12 Nonetheless, exercise training during cancer treatment has demonstrated to be safe, feasible and associated with significant improvement in exercise capacity, symptoms and some domains of HRQoL.^7,9,13,14

Furthermore, it has been confirmed that peak oxygen consumption is a strong independent predictor of overall long-term survival for individuals with NSCLC, while low exercise tolerance is associated with poor thoracic surgical outcomes.^10,15

Lung cancer is one of the most prevalent types of cancer and research that investigates effects of exercise intervention or aims at developing PR programmes specific to these patients is increasing. However, optimal design of exercise intervention, tailored to lung cancer patients, either pre- or post-surgery, has yet to be established.^9,13

In recent years, Crandall et al.⁹ have published a systematic review of literature regarding effectiveness of exercise in patients surgically treated for NSCLC, either pre- or post-surgery. Crandall et al.⁹ concluded that there is insufficient evidence to design the most suitable exercise intervention for patients surgically treated for NSCLC, suggesting that higher quality randomised controlled trials (RCTs) are required.⁹

Furthermore, Cavalheri et al.,¹⁶ in 2014, published a Cochrane review about the effects of postoperative exercise training in NSCLC patients. The authors concluded that exercise training may potentially increase physical capacity of individuals following surgery, but their results should be interpreted with caution due to disparities of studies, methodologic limitations, significant risk of bias and small sample sizes of clinical trials analysed in that review.¹⁶

Our final aim is to define and implement the most updated and evidence-based physical exercise interventions directed at patients surgically treated for NSCLC, both pre- and post-surgery. These programmes will become part of an experimental intervention in a future clinical trial designed to investigate the effects of physical therapy on surgical candidates with lung cancer.

The Cochrane Collaboration recommends periodic updating of literature search (e.g. every 2 years) to determine whether any new relevant information is available.¹⁷ Thus, considering the good methodological quality of the previous systematic review of Crandall et al.⁹ and similarities with the objectives this study, we have chosen to update their review and to take into consideration the previous results of Cavalheri et al.¹⁶

Accordingly, we have carried out this systematic review, examining the best evidence regarding PR, focusing mainly on the physical training component for preoperative and postoperative interventions in patients with lung cancer undergoing surgery.

Materials and methods

We searched the following databases from May 2013 to May 2016:

• MEDLINE;

• EMBASE;

• CINAHL;

• Cochrane Library;

• PsycINFO.

The search strategy is reported in Appendix 1 and is identical to the strategy used by Crandall et al.⁹ up to May 2013.

Inclusion criteria

Studies were included in the review according to the following criteria:

• Population. Trials that included participants who underwent surgery for NSCLC with curative intent. We excluded trials which included patients who underwent exclusively chemotherapy and/or radiotherapy because of the impact of these therapies would have on outcome measures and different prognosis of this population.

• Intervention. Any supervised or unsupervised, inpatient or outpatient or home-based PR exercise-training programme. The exercise programme had to be described in sufficient detail in order to be reproducible.

• Outcome measures. Exercise capacity, lung function, HRQoL and postoperative pulmonary complications (PPCs).

• Methodology. Since this study investigates treatment efficacy, only RCTs were searched.

• Language. Reports published in English, French, Italian, Portuguese and Spanish.

Study selection

Two reviewers (P.F.S.R., C.M.) reviewed all the records retrieved in order to check for inclusion criteria. They preliminarily screened titles and abstracts and then retrieved and analysed the full text of studies judged appropriate for study purposes. In case of disagreement, the opinion of a third reviewer was asked (S.C.).

Assessment of methodological quality

Two reviewers (P.F.S.R., C.M.) assessed methodological quality of each study according to the Cochrane Collaboration risk of bias tool.¹⁸ In case of disagreement, the opinion of a third reviewer was asked (S.C.).

Data extraction

For every RCT included, two reviewers (P.F.S.R., C.M.) extracted the following data:

• Participants: gender, age, type of surgery;

• Intervention: type of exercise, intensity, length of intervention, duration of session, frequency, supervision (provided/not provided), individual versus group session, inpatient versus outpatient and/or home-based regimen;

• Outcome measures collected;

• Results.

When essential data were missing, the investigators requested them from authors.

Results

Bibliographic search results

We retrieved 556 references without duplicates. After preliminary review of titles and abstracts, we excluded 461 studies because their main subject was not related to our research question, 68 because they did not meet inclusion criteria, 5 because they were already present in the review by Crandall et al.⁹ and 1 study because only protocol was published.¹⁹ Of the remaining 21 studies, 2 were editorials^20,21 and 5 were published as abstracts^22–26 and therefore data were not complete. Regarding these abstracts, two^22,26 were excluded because they were already included as full texts^27,28 in our initial bibliographic research. Concerning the three remaining abstracts, we contacted the corresponding authors in order to obtain complete data. In one case,²⁵ the authors provided the requested data, whereas in the other two cases, our attempts were unsuccessful.^22,23 Consequently, we analysed 15 studies. Upon reading the full text, nine studies were excluded from our review because they did not meet inclusion criteria: six studies were not RCTs,^29–34 two studies did not entirely focus on patients who underwent surgery for NSCLC, as it also included patients receiving exclusively chemotherapy and/or radiotherapy,^35,36 and one study²⁸ because it was only a feasibility study and was not focused on the effectiveness of exercise training. Therefore, six RCTs were included in this review.^{8,25,27,37–39} The flow chart representing selection process of studies is reported in Figure 1.

Figure 1.

Flow chart of study selection.

Characteristics of included studies

The included studies were parallel RCTs and participants were randomised into an experimental intervention group (IG) or control group (CG).

One of the included studies focused on preoperative PR,³⁷ while the other five focused on postoperative PR.^{8,25,27,38,39} Detailed study characteristics are presented in Table 1.

Table 1.

Study characteristics.

Reference	PRE/POST intervention	Patients	Type of surgery	Demographic characteristics of patients
				Age (mean ± SD years)
				IG	CG
Stefanelli et al.37	PRE	40	100% thoracotomy	65.5 ± 7.4	64.8 ± 7.3
Arbane et al.39	POST	131	70.3% thoracotomy, 29.7% VATS	67 ± 11	68 ± 11
Brocki et al.8	POST	78	76.9% thoracotomy, 23.1% VATS	64 ± 10	65 ± 9
Edvardsen et al.38	POST	61	83.6% thoracotomy, 16.4% VATS	64.4 ± 9.3	65.9 ± 8.5
Cavalheri et al.25	POST	17	47% thoracotomy, 53% VATS	66 ± 10	68 ± 9
Hoffman et al.27	POST	87	90% thoracotomy, 10% VATS	67.4 ± 9.7	65.6 ± 10.1

PRE: preoperative; POST: postoperative; SD: standard deviation; IG: intervention group; CG: control group; VATS: video-assisted thoracoscopic surgery.

Participants

The sample size of preoperative trial consisted of 40 participants with an average age of 65 ± 7 years.³⁷ Overall, the five postoperative trials included 374 participants (range, 17–131); 191 were randomised into the experimental IG and 183 into the control one. In all, 278 of the 374 randomised patients completed follow-up (74.3%). Follow-up took place at different time points: at 4 weeks after surgery,³⁹ at 6 weeks after surgery,²⁷ at 8 weeks after baseline assessment,²⁵ at 20 weeks after intervention³⁸ and 1 year after the baseline assessment.⁸ In all, 139 of these follow-up patients were allocated to the IG and 139 to the control one. Studies recruited both males and females, and average age of participants was 66 ± 10 years.

Methodologic quality

Methodologic quality of the included studies is reported in Figures 2 and 3.

Figure 2.

Risk of bias analysis of preoperative study.

Figure 3.

Risk of bias analysis of postoperative studies.

None of the studies reported blinding of participants and personnel. Four^{8,25,27,38,39} out of five²⁷ postoperative studies reported blinding of outcome assessors, and the preoperative study³⁷ did not report sufficient information to evaluate this aspect. However, the studies of Stefanelli et al.³⁷ and Hoffman et al.²⁷ were deemed as a low risk for detection bias, since outcomes analysed in these studies are usually measured in an objective manner. Risk of bias for included studies is reported in Appendix 2.

Characteristics of PR programmes

Table 2 summarises the characteristics of PR programmes described by the included studies.

Table 2.

PR programme characteristics.

Reference	Group	Exercise type	Intensity	Length of intervention	Session duration	Frequency	Supervised/unsupervised	Group/individual	Inpatient/outpatient/home-based
Stefanelli et al.37 (PRE)	IG	• Respiratory exercises on bench, mattress pad and wall bars, respectively; • AT: upper limbs with rowing ergometer, lower limbs by means of treadmill and ergometric bicycle	70% of the maximum score reached at CPET and increased by 10 W when the patient was able to tolerate the set load for 30 min	3 weeks	3 h	5 sessions/week	Supervised	Individual	Out
	CG	• Usual care – no exercise
Brocki et al.8 (POST)	IG	• AT: stationary bike; • ST: arms (green Thera-band®), trunk (abdomen, back), legs (step-ups, heel-raises, sit-to-stands); • Home exercises (strength training at least twice a week and a daily 30 m walk or bicycle ride with intensity of 11–12 RPE); • Usual postoperative nurse counselling, 3 individual sessions of 1 h 30 min; • Dyspnoea management techniques	• AT: RPE 11–12 (1–4 sessions); RPE 13–16 (5–10 sessions) • ST: 6–10 rep, 1–2 sets • Home exercises: 11–12 RPE	10 weeks	15 min warm-up; 20 min aerobic exercise; 15 min muscle strength training; 10 min cool-down/relaxation Total 1 h	1 session/week from 3rd week after surgery to 13th week	Supervised	Group	Out
	CG	• Home exercises (strength training at least twice a week and a daily 30 min walk or bicycle ride with intensity of 11–12 RPE); • Usual postoperative nurse counselling, three individual sessions of 1 h 30 min	• Home exercises: 11–12 RPE						Home-based
Arbane et al.39 (POST)	IG	• AT: bicycle; • ST: 10 RM using ankle weights • Usual care: routine physiotherapy treatments, airway clearance techniques where indicated, mobilisation and upper limb activities; • At home: SPACE walking programme for people with COPD	• AT: 50–60 r/min with the intensity increased steadily during the third minute to achieve a maximum of 60%−90% of heart rate reserve and to 3 or 4 on BBS and 13–15 on RPE	Length of hospital stay (about 5 days); SPACE from discharge	• AT: Starting from 5 min to 30 min in total (with 2 min warm-up and 2 min cool-down)	Daily	Supervised SPACE: unsupervised	Individual	In SPACE: Out
	CG	• Usual care – routine physiotherapy treatments, airway clearance techniques where indicated, mobilisation and upper limb activities
Edvardsen et al.38 (POST)	IG	• AT: walking uphill on treadmill; • ST: progressive resistance training • IMT	• AT: 80%−95% MHR; • ST: 3 series of 6–12 RM of leg press, leg extension, back extension, seat row, bicep curls and chest-and-shoulder press	20 weeks	1 h	• AT and ST: 3 sessions/week; • IMT: daily	• AT and ST: Supervised; • IMT: Unsupervised	2 weekly sessions individual; 1 weekly session group, if possible	Out
	CG	• Usual care – general information
Cavalheri et al.25 (POST)	IG	• AT: walking along 100-m corridor or on a treadmill, or cycle ergometera; • ST: step-ups (undertaken within parallel bars) and exercises with hand weights for the biceps brachii muscle and deltoid muscle	• AT: for corridor walking initial speed set at 80% of the average 6MWT speed; for treadmill walking, initial speed set at 70% of the average 6MWT speed. Walking speed increased when participants were able to walk 20 min continuously with symptoms and SpO2 within acceptable limits (⩾88%) Cycle ergometera:10 min of endurance training (initial work rate was set at 60% of the Wmax achieved during the CPET) and two periods of 2 min of power training (initial work rate was set at 80% of the Wmax achieved during the CPET performed at the baseline assessment) • ST: step-ups in 2 sets of 10 repetition; upper limb training in 3 sets of 10 repetitions (initial weights: 1.5 kg for women and 2 kg for men)	8 weeks	60 min	3 sessions/week	Supervised; cycle ergometera unsupervised	Individual	Out; cycle ergometera home-based
	CG	• Usual care – no exercise
Hoffman et al.27 (POST)	IG	• AT: walking in place with the Wii • Balance exercises from a menu of predetermined Wii balance exercises	• AT: 5 min during week 1 and continued to build by 5 min/day each week with the goal of walking with the Wii of 30 min/day during week 6. The duration was increased by 5 min each week if the participant’s PSE for attaining that duration was 70% or greater on a 0%−100% scale, with 100% having the highest PSE	6 weeks	Variable: from 5 to 30 min	5 sessions/week (5 days a week for weeks 1–6)	Unsupervised	Individual	Home-based
	CG	• Usual care – without exercise

IG: intervention group; CG: control group; UL: upper limb; rep: repetitions; AT: aerobic training; IMT: inspiratory muscle training; MIP: maximal inspiratory pressure; CPT: chest physical therapy; CPET: cardiopulmonary exercise test; ST: strength training; RPE: Borg rating of perceived exertion; SPACE: Self-management Programme of Activity, Coping and Education; COPD: chronic obstructive pulmonary disease; BBS: Borg CR10 Breathlessness Scale; RM: repetition maximum; MHR: maximum heart rate; 6MWT: Six-Minute Walk Test; PSE: perceived self-efficacy.

^aIn the event that a participant could only attend two supervised sessions per week, they were provided with a cycle ergometer (OBK600A; Orbit fitness equipment, Perth, WA, Australia) to use at home for one training session per week.

Preoperative rehabilitation programme

Regarding the preoperative PR, Stefanelli et al.³⁷ included incremental high-intensity aerobic training, both for lower and upper limbs and respiratory exercises. The PR programme lasted 3 weeks, consisting of five supervised individual sessions per week, conducted in an outpatient setting. The CG received usual care but further details were not reported.

Postoperative rehabilitation programmes

Postoperative programmes included aerobic and strength or balance training. Regarding the respiratory component, Edvardsen et al.³⁸ included inspiratory muscle training (IMT), Arbane et al.³⁹ incorporated routine physiotherapy treatments and Brocki et al.⁸ incorporated dyspnoea management techniques.

The intervention described by Hoffman et al.²⁷ was a 6-week, home-based, unsupervised, walking and balance exercise programme using Nintendo Wii Fit Plus. The walking programme started off at 5 min/day for the first 5 days in week 1. Duration was increased every week in order to reach the goal of continuous walking for 30 min/day by week 6. Participants also performed a series of programmed balance exercises 5 days a week from week 1 to week 6. The CG performed usual care and was not given any advice concerning exercise.

The intervention programme of Cavalheri et al.²⁵ consisted in an 8-week individual, supervised, inpatient training 3 days/week comprising aerobic and resistance training. If some participants could only attend two supervised sessions per week, they were provided with a cycle ergometer (OBK600A; Orbit fitness equipment, Perth, WA, Australia) to use at home for one training session per week. The CG was instructed to continue performing their usual activities; in addition, they received weekly phone calls from a research assistant who asked them general questions about their health and well-being.

The intervention described by Edvardsen et al.³⁸ was a 20-week, high-intensity programme consisting of three outpatient sessions per week, one being a group session, when possible. Aerobic and strength training were supervised, whereas IMT was unsupervised and performed daily. CG performed usual care and was not given any advice regarding exercise, besides routine general information.

The intervention programme of Arbane et al.³⁹ consisted first in daily inpatient sessions, lasting about 5 days, up to discharge; after that, patients initiated Self-Management Programme of Activity, Coping and Education (SPACE) in an unsupervised and outpatient setting. The CG received usual care including routine physiotherapy treatments, airway clearance techniques, mobilisation and upper limb activities.

The intervention programme of Brocki et al.⁸ consisted of weekly group rehabilitation sessions lasting 10 weeks, starting from the third post-surgery week. Sessions were supervised in an outpatient setting. This programme also included three individual sessions of postoperative nurse counselling, lasting one and a half hours, as part of usual care provided for both groups. Furthermore, the CG was given a home-based exercise programme including aerobic and strength training.

Outcome measures

Table 3 summarises outcome measures analysed in included studies.

Table 3.

Outcome measures.

Reference	PRE/POST	Exercise capacity	HRQoL
Stefanelli et al.37	PRE	VO2 peak (CPET)
Hoffman et al.27	POST	6MWT	SF-36
Cavalheri et al.25	POST	6MWT and VO2 peak (CPET)	SF-36 + FACT-L + EORTC QOL C-30
Edvardsen et al.38	POST	VO2 peak (treadmill)	SF-36 + EORTC QOL C-30 dyspnoea
Arbane at al.39	POST	ISWT	SF-36 + EORTC QOL-LC13
Brocki et al.8	POST	6MWT	SF-36

PRE: preoperative; POST: postoperative; HRQoL: health-related quality of life; CPET: cardiopulmonary exercise test; 6MWT: Six-Minute Walk Test; SF-36: Short Form 36; FACT-L: Functional Assessment of Cancer Therapy – Lung scale; EORTC QOL: European Organisation for Research and Treatment of Cancer Quality Of Life; ISWT: Incremental Shuttle Walk Test.

Preoperative study

Exercise capacity was analysed by Stefanelli et al.³⁷ by means of VO_2peak (maximum consumption of O₂ at exercise peak) using the cardiopulmonary exercise test (CPET).

Regarding lung function, Stefanelli et al.³⁷ analysed forced expiratory volume in first second (FEV₁) and diffusing lung capacity of carbon monoxide (DLCO).

Postoperative studies

All trials measured exercise capacity. Edvardsen et al.³⁸ analysed VO_2peak using a continuous graded exercise protocol on a treadmill. Brocki et al.⁸ and Hoffman et al.²⁷ used Six-Minute Walk Test (6MWT). Cavalheri et al.²⁵ used 6MWT and VO_2peak performing also CPET. Arbane et al.³⁹ measured exercise capacity with Incremental Shuttle Walk Test (ISWT). They also recorded activity levels with an Actiwatch that was given to patients to wear at least 48 h preoperatively and then for 5 days post-surgery (or until discharge, if earlier). Participants were given the Actiwatch again 1 week prior to the 4-week postoperative assessment and were asked to wear it for at least 5 days.

Lung function was analysed in three trials. Cavalheri et al.²⁵ analysed FEV₁, functional vital capacity (FVC), total lung capacity and DLCO. Edvardsen et al.³⁸ reported FEV₁ and DLCO and Brocki et al.⁸ analysed FEV₁ and FVC.

HRQoL was assessed through Short Form-36 questionnaire (SF-36) in all trials^{8,25,27,38,39} and three of them also used the European Organisation for Research and Treatment of Cancer questionnaire (EORTC).^25,38,39 Cavalheri et al.²⁵ analysed HRQoL using also the Functional Assessment of Cancer Therapy – Lung scale (FACT-L).

PR programme effectiveness

Preoperative study

Stefanelli et al.³⁷ trial reported that differences between groups were null at baseline. Instead, at T1 (after preoperative rehabilitation and pre-surgery) and at T2 (60 days post-surgery), it showed a significant difference in VO_2peak between groups in favour of the IG (p < 0.001 and p < 0.01, respectively). Furthermore, in the IG, they observed a within-group significant improvement in VO_2peak from baseline to T1. This improvement was not maintained after surgery, when patients in the IG fell back to their baseline values. On the contrary, within the CG, VO_2peak registered a continuous decrease at both time points. Significant worsening after surgery brought this group to a level lower than baseline. Regarding lung function, this trial failed to report any between-group differences. Yet, it reported a significant within-group decrease of DLCO and FEV₁, from baseline to T1 and from T1 to T2 for both IG and CG.

Postoperative studies

Regarding exercise capacity, Hoffman et al.²⁷ reported a significant delta difference in distances at 6 weeks post-surgery versus pre-surgery (p < 0.001). Cavalheri et al.²⁵ reported greater gains favouring IG for VO_2peak (mean difference (95% confidence interval (CI)) 0.19 (0.04–0.33) L/min), O₂ pulse (2 (0–3) mL/beat) and anaerobic threshold (11 (1–21)% of VO_2peak); regarding 6MWT, the authors reported greater favouring IG for distance walked (mean difference (95% CI of difference) 52 (12–93) min). Edvardsen et al.³⁸ reported a significant difference between groups in VO_2peak after postoperative PR (p = 0.02), favouring IG. Arbane et al.³⁹ did not clearly report exercise capacity levels measured by ISWT. We tried to contact the corresponding author to obtain complete data but our attempts were unsuccessful. Nevertheless, from data presented graphically in this study, it seems that, after postoperative PR, CG did not improve exercise capacity, whereas in IG, it improved by 60 min. However, we do not know if this difference was statistically significant. Also, using intention-to-treat analysis, they found no between or within-group significant differences for total active time, measured by Actiwatch, 4 weeks post-surgery. Brocki et al.⁸ showed an improvement in walking distance 4 months and 1-year post-surgery in both groups, with no between-group differences at any time.

Lung function, analysed in Cavalheri et al.,²⁵ Edvardsen et al.³⁸ and Brocki et al.⁸ trials, did not present significant changes in FEV₁ and FVC; only DLCO, reported by Edvardsen et al.,³⁸ presented significant differences between groups after PR (p = 0.01), supporting IG.

In relation to HRQoL, the study by Hoffman et al.²⁷ showed a within-group improvement in IG after intervention for mental and physical domains of SF-36, but we cannot determine if this difference was statistically significant between groups because data were not completely reported. The study by Cavalheri et al.²⁵ reported no between-group differences in the three rating scales used. The study by Edvardsen et al.³⁸ reported significant differences between groups after intervention in both physical and mental domains of SF-36 (p = 0.006 and 0.02, respectively), supporting the experimental programme. Moreover, this trial analysed dyspnoea dominium of EORTC and found a significant improvement in IG (p = 0.03). The trial conducted by Brocki et al.⁸ found no statistical differences between groups in any of the SF-36 domains, except for the one dealing with body pain, which revealed a statistically significant improvement favouring IG 4 months post-surgery (p = 0.01). Arbane et al.³⁹ stated no significant differences in quality of life between IG and CG, measured either by SF-36 or EORTC. However, when the subgroup with airflow obstruction was analysed, they found that the experimental exercise programme significantly prevented a decline in both mental and physical domains of SF-36 (0.01 and 0.04, respectively). Table 4 summarises HRQoL data collected by all the included studies using SF-36.

Table 4.

SF-36 data.

	Reference	Assessment	IG				CG				Between-group difference (95% CI)	p value IG-CG
			N	Mean ± SD	Mean change from baseline ± SD	95% CI	N	Mean ± SD	Mean change from baseline ± SD	95% CI
Physical domain	Hoffman et al.27	Baseline (before surgery)	37	48.02 ± 9.3			35	46.1 ± 9.2				0.35
		Post-surgery	37	30.2			35	32.7				NR
		3 weeks post-surgery	37	41.5a			35	35.5a				NR
		6 weeks post-surgery	37	45.2			35	38.8				NR
	Cavalheri et al.25	Baseline (6–10 weeks post-surgery)	9	46 ± 6		2 (−3 to 6)	8	42 ± 5		−2 (−7 to 2)		NR
		8 weeks after baseline	9	48 ± 8			8	40 ± 9			4 (−2 to 10)	0.20
	Edvardsen et al.38	Baseline (4–6 weeks post-surgery)	30	48.3 ± 9			31	48.3 ± 11.9			NR	NS
		After PR (20 weeks)	30	51.8 ± 5.5			31	43.3 ± 11.3				0.006
	Arbane et al.39a	4 weeks post-surgery	40	17		8.5–26.2	38	23		10.3 to 35.8	12 (0.5–23)	0.04
	Brocki et al.8	Baseline (3 weeks post-surgery)	41	38.88 ± 10			37	38.99 ± 7			NR	NR
		4 months after baseline	32		6.7 ± 8		35		3.1 ± 9.2		3.76 (−0.1 to 7.62)	0.06
		1 year after baseline	27		5.1 ± 11.1		31		7.7 ± 8.5		−1.5 (−5.6 to 2.5)	0.27
Mental domain	Hoffman et al.27	Baseline (before surgery)	37	48.1 ± 10.6			35	50 ± 10.4				0.46
		Post-surgery	37	51.5a			35	44.5a				NR
		3 weeks post-surgery	37	52.5a			35	47.4				NR
		6 weeks post-surgery	37	57.5			35	47				NR
	Cavalheri et al.25	Baseline (6–10 weeks post-surgery)	9	55 ± 6		−4 (−12 to 5)	8	46 ± 6		5 (−2 to 12)		NR
		8 weeks after baseline	9	51 ± 14			8	51 ± 8			−8 (−18 to 2)	0.10
	Edvardsen et al.38	Baseline (4–6 weeks post-surgery)	30	46.4 ± 11.1			31	45.4 ± 12.1			NR	NS
		After PR (20 weeks)	30	55.5 ± 5.3			31	46.6 ± 14				0.020
	Arbane et al.39b	4 weeks post-surgery	40	2		−11.2 to 14.3	38	15		0.8 to 30	20 (4.6 to 34.6)	0.01
	Brocki et al.8	Baseline (3 weeks post-surgery)	41	45.67 ± 10			37	44.88 ± 9			NR	NR
		4 months after baseline	32		4.4 ± 10.4		35		5.4 ± 9.4		−0.03 (−3.7 to 3.6)	0.99
		1 year after baseline	27		5.33 ± 8.7		31		9.6 ± 9		−2.15 (−6 to 1.7)	0.27

IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; NR: not reported; NS: not significant.

^aData estimated, presented graphically.

^bData refer to the subgroup with airflow obstruction.

Appendix 3 summarises detailed results for every outcome collected by the included studies in order to assess effects of experimental interventions.

Discussion

This systematic review aimed at determining the best evidence-based physical exercise interventions directed at patients treated surgically for NSCLC, both pre- and post-surgery.

Regarding preoperative and postoperative PR, our review demonstrates that in this field literature is lacking a sufficient number of randomised clinical trials. Therefore, beyond the previous conclusions of Crandall et al.,⁹ highlighting the need for further high-quality RCTs and suggesting that an optimal rehabilitation programme should include aerobic, strength and breathing exercises,⁹ we cannot add any relevant evidence. However, our results allow us to support previous findings of Cavalheri et al.,¹⁶ suggesting inclusion of exercise training in PR programmes after lung resection for NSCLC.¹⁶

Preoperative PR

Concerning the effects of exercise training for people undergoing lung resection, we found only one RCT published in the last 2 years.³⁷ Moreover, findings of this study should be analysed with caution due to questionable methodologic quality, since randomisation method was not clearly described and attrition and reporting biases are likely to have affected results. Furthermore, the authors did not provide any information about blinding of assessors. However, outcomes measured in this study were instrumentally determined by precise guidelines, consequently blinding of assessors may not have been so essential. Regarding exercise-training programme, this trial followed current physical activity guidelines for PR in cancer patients (2–4 weeks, 5 times/week).¹⁰ This training modality is feasible, although its efficacy has not yet been clearly confirmed by large sample size studies.¹⁰ The trial of Stefanelli et al.³⁷ exhibited a beneficial effect of preoperative PR on physical performance in patients with COPD and NSCLC, even if no improvements in lung function were revealed. This result should be interpreted in light of the fact that exercise training was associated with significant increase in VO_2peak, as confirmed by previous studies.^40,41 Also, it is well documented that cardiorespiratory fitness is a strong independent predictor of postoperative complications and survival in NSCLC patients after lung resection.^15,42,43 So, even if Stefanelli et al.³⁷ did not assess PPCs, we may infer that preoperative PR could reduce postoperative respiratory morbidity, length of hospital stay and health-care costs due to improvements in cardiorespiratory fitness induced by enhanced physical performance.^44,45

Even though our research focused mainly on exercise training, we noticed that preoperative PR programmes often integrate a respiratory component, which frequently includes IMT.^44,45 Indeed, a previous meta-analysis concluded that preoperative IMT significantly improves respiratory muscle function.⁴⁶ Hence, we suggest including this specific component in preoperative PR programmes.

Postoperative PR

Regarding postoperative PR, the five RCTs included in our review showed a good methodologic quality.^{8,25,27,38,39} These five studies were classified at low risk of bias for almost every parameter, except for the risk of performance bias. However, it is necessary to point out that, in the rehabilitation field, it is very difficult to guarantee participant and personnel blinding. For this reason, it is critically important to assure blinding of outcome assessors, as seen in four^8,25,38,39 out of five²⁷ studies included in our review.

Concerning the effect of postoperative PR on physical capacity, the variability in PR programmes and outcome measures applied in the included studies prevented us from adding any relevant evidence to the previous systematic reviews.^9,16 One of the included studies showed beneficial effects on cardiorespiratory fitness after supervised endurance and strength training, measured by VO_2peak³⁸ and another one²⁷ showed an increase in the walking distance up to preoperative levels. Another study showed beneficial effects in both CPET and 6MWT.²⁵ These results are in accordance with the meta-analyses performed by Cavalheri et al.,¹⁶ supporting increase in physical capacity through exercise training in this population. Conversely, the other two trials^8,39 revealed no differences between groups for physical capacity, with similar increases in walking distance and recovery up to preoperative functional levels in both groups. However, the results of Arbane et al.³⁹ should be considered with caution, since this study reported high number of lost to follow-up patients (27% in CG and 17% in IG); so, the risks of attrition bias and type II error cannot be entirely excluded. Regarding the trial of Brocki et al.,⁸ it is important to point out that some form of physical training was included in both IG and CG. Indeed, the authors intended to compare supervised versus unsupervised exercise training and outpatient versus home-based settings. Their results were not statistically significant but tended to show a slightly faster recovery through supervised exercise.

Concerning pulmonary function, our review does not demonstrate any changes after postoperative PR programmes, in accordance with Crandall et al.⁹ and Cavalheri et al.¹⁶ reviews and with previous research conducted on COPD patients.⁴⁷

Regarding HRQoL, our review suggests that exercise training could be advantageous. Even if results were not exactly identical in the included trials, four^8,27,38,39 out of five²⁵ studies reported a certain degree of change in HRQoL using SF-36, always favouring IG. Certainly, there is still little evidence concerning the effects of exercise training on HRQoL, as also observed by Crandall et al.⁹ and Cavalheri et al.¹⁶ In addition, it has been shown that lung resection for NSCLC has a greater detrimental impact on quality of life compared to other major visceral surgeries.⁴ Perhaps for this reason, research in this field has started to focus not only on functional outcome measures but also on quality of life as perceived by patients. Although NSCLC survivors are extremely vulnerable and, consequently, need time to recover from treatment,⁴ there is now a growing body of evidence regarding this topic. Possibly, more prolonged treatments over time may have more decisive effects on this outcome.

The five postoperative trials included in our review presented various forms of PR programmes. They were similar only in one type of exercise included (aerobic), but each study also added different kinds of training (strength or balance) and they also differed in setting, session duration, intensity, length of intervention and frequency. These dissimilarities made it difficult to identify the best exercise intervention design. Even if it was not possible to establish the best evidence-based physical exercise intervention, previous studies support the inclusion of aerobic exercise training combined with other forms of exercise,^11,31 such as strength training, as suggested by recent guidelines¹⁰ and systematic reviews^9,48 on optimal perioperative PR programmes for lung cancer patients. Considering that the majority of patients affected by lung cancer also present COPD,³ exercise-training programmes specific for this population are often based on COPD training programmes and are frequently associated with a respiratory component. This component is usually made up of IMT,^12,38 incentive spirometry,⁴⁹ airway clearance techniques³⁹ and respiratory exercises.¹⁹

Regarding location of exercise intervention, there is no evidence that allows us to indicate the best setting or any other features of rehabilitation programmes. In any case, a recent review by Maguire et al.⁵⁰ analysed needs of people living with lung cancer and highlighted the importance of addressing fatigue, dyspnoea, pain, difficulties in daily activities, psychological distress and return to work issues. These domains should be included in any rehabilitation programme. Moreover, educational sessions would be useful in order to empower people to cope better with their disease. This review also pointed out difficulties in accessibility to health-care programmes due to transportation problems. Therefore, when defining and choosing an intervention programme, it is of utmost importance to consider patient needs and availability of local health-care services. Thus, the best PR programme would probably reflect a combination of supervised outpatient and unsupervised home-based training. Furthermore, bearing in mind the psychological condition of NSCLC patients, the inclusion of group sessions might be beneficial for sharing experiences and facilitating social domain.⁵¹ Supporting this theme, a study conducted by Swenson et al.⁵² reported that patients attending group sessions were more likely to complete the programme. Furthermore, the authors declare that group setting was acceptable and beneficial for this population.⁵²

Recent literature has demonstrated that either pre- or post-operative exercise training for NSCLC patients is safe, feasible and acceptable.^7,9,13 In our review, none of the included studies reported data regarding safety of the applied intervention. In all, 96 of the 374 patients randomised dropped out. Surely, a drop-out rate of 26% might indicate limited acceptability or feasibility, although in this population a similar rate of withdrawal might be considered normal, as also reported by a recent study of Sommer et al.²⁸ Nevertheless, the majority of patients lost to follow-up were found in only one study³⁹ and the reason for this drop-out rate concerned, in most cases, loss of inclusion criteria.

This review has some limitations. First, we only analysed the last 3 years of published literature; however, we choose not to search for older publications because two extensive and well-done systematic review had been published in recent years.^9,16 Second, although we only focused on collecting evidence regarding exercise training programmes, we recognise that other rehabilitation interventions (i.e. chest physiotherapy, educational or psychological programmes, nutritional interventions) might be beneficial in this population. Finally, the clinical trials included in this review showed different quality levels and were not completely free of risk of bias, although we know that a certain risk of bias may almost always be present in studies conducted in the field of rehabilitation. Regardless of different quality levels of evidence, this review suggests that inclusion of exercise-training programmes should be considered for this population, both pre- and post-surgery. In particular, exercise training may have an important role for patients that already have compromised functional capacity or present comorbidities, such as COPD.^9,11,16,53

In conclusion, this review has shown that, because of insufficient number of RCTs and substantial heterogeneity between types of interventions, it is not possible to establish the best exercise intervention programme, either pre- or post-surgery, for patients surgically treated for NSCLC. Nevertheless, this review further emphasises the complexity of PR for this population. Interventions often include several interacting components such as exercise training, IMT, incentive spirometry, airway clearance techniques and respiratory exercise. This systematic review highlights the urgent need for additional and larger RCTs with better methodology, in order to collect stronger evidence and clarify the role of exercise-training programmes for these patients. Finally, we should highlight the value of both pre- and post-surgery physical training programmes, implemented in a multidisciplinary environment, that include aerobic training as the most relevant component to improve exercise capacity.

Clinical messages

• Urgent need for additional and larger RCTs with better methodological quality in order to identify the best physical exercise interventions design for surgically treated NSCLC patients.

• Literature suggests inclusion of both aerobic and strength training in an optimal perioperative PR programme.

Appendix 1

Strategy research

S1.	exp Lung Neoplasms/
S2.	lung cancer.mp.
S3.	lung neoplasm*.mp.
S4.	Non-Small-Cell Lung.mp.
S5.	1 or 2 or 3 or 4
S6.	exp Exercise/
S7.	exp Exercise Therapy/
S8.	exp Physical Fitness/
S9.	exp Rehabilitation/
S10.	exp Physical Therapy Modalities/
S11.	exercise.mp.
S12.	physical activity.mp.
S13.	physical fitness.mp.
S14.	rehabilitation.mp.
S15.	exercise therapy.mp.
S16.	6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15
S17.	exp General Surgery/
S18.	exp Pulmonary Surgical Procedures/
S19.	exp Thoracic Surgical Procedures/
S20.	exp Surgical Procedures, Operative/
S21.	surg*.mp.
S22.	operat*.mp.
S23.	resection.mp.
S24.	lobectomy.mp.
S25.	17 or 18 or 19 or 20 or 21 or 22 or 23 or 24
S26.	5 and 16 and 25
S27.	remove duplicates from 26

Note that the suffix exp = exploded term, / = MeSH and mp. = title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept, rare disease supplementary concept and unique identifier (free-text term).

Appendix 2

Risk of bias analysis

Item	Authors’ judgement	Description
Preoperative: Stefanelli et al. 37
Sequence generation	Unclear	Quote: ‘Patients were randomly assigned to two groups’ Comment: insufficient to be confident that the allocation sequence was genuinely randomised
Allocation concealment	Unclear	Quote: ‘Patients were randomly assigned to two groups’ Comment: probably not done, no information about the allocation concealment
Blinding of participants and personnel	High risk	Open label
Blinding of outcome assessment	Low risk	Comment: blinding of outcome assessment is not reported but the outcomes considered in our review (VO2 peak, FEV1, FVC, DLCO) are not likely to be influenced by lack of blinding
Incomplete outcome data	High risk	No defined number of patients at the follow-up
Selective reporting	High risk	FVC data not reported
Other bias	High risk	Number of patients in IG and CG are not reported
Postoperative: Hoffman et al. 27
Sequence generation	Low risk	Quote: ‘A random-number table was generated by the team statistician to identify whether the potential participant was assigned to the IG or CG. The random-number table included decimal numbers between 0 and 1’.
Allocation concealment	Low risk	Quote: ‘The random allocation was a predefined assigned slot when a patient enrolled in the study. The recruiter used the next available predefined slot for allocation’
Blinding of participants and personnel	High risk	Open label
Blinding of outcome assessment	Low risk	Assessors were not blinded to patient’s group allocation but outcomes considered in this study and extracted for our review (6MWT, SF-36) are not likely to be influenced by lack of blinding
Incomplete outcome data	Low risk	Quote: ‘All analyses were completed on the randomized groups by intent to treat’
Selective reporting	High risk	6MWT and SF-36 data are reported incompletely
Other bias	Low risk	Study appears to be free of other sources of bias
Postoperative: Cavalheri et al. 25
Sequence generation	Low risk	Quote: ‘The randomisation sequence was generated and managed by an independent researcher using a computer …’
Allocation concealment	Low risk	Quote: ‘… and concealed using sequentially numbered opaque envelopes’
Blinding of participants and personnel	High risk	Open label
Blinding of outcome assessment	Low risk	Assessors were blinded to patient’s group allocation.
Incomplete outcome data	Low risk	Quote: ‘Analyses were undertaken according to the intention-to-treat principle’
Selective reporting	Low risk	All pre-specified outcomes were reported
Other bias	Low risk	Study appears to be free of other sources of bias
Postoperative: Edvardsen et al. 38
Sequence generation	Low risk	Quote: ‘The randomisation was done in blocks with varying block size (4–6 subjects)’
Allocation concealment	Low risk	Quote: ‘… put into sealed opaque envelopes generated by an external statistician’
Blinding of participants and personnel	High risk	Open label
Blinding of outcome assessment	Low risk	Quote: ‘… single-blind single-centre randomised controlled trial’; ‘… we cannot rule out the possibility that the technicians were not blinded during the last data collection’ Comment: outcomes considered in this study and extracted for our review (VO2peak, FEV1, SF-36, EORTC) are not likely to be influenced by lack of blinding
Incomplete outcome data	Low risk	Missing data have been imputed using intention-to-treat analysis
Selective reporting	Low risk	All pre-specified outcomes were reported
Other bias	Low risk	Study appears to be free of other sources of bias
Postoperative: Arbane et al. 39
Sequence generation	Low risk	Quote: ‘The randomisation sequence was created using StataVersion 9.0 (StataCorp, College Station, TX, USA) and was stratified by centre with a 1:1 allocation using random block sizes of two, 4 and six. … The online randomisation service provided by the Mental Health and Neurosciences Clinical Trials Unit supplied by King’s College London’
Allocation concealment	Low risk	Quote: ‘The allocation sequence was concealed from the researcher who enrolled and assessed the participants. … This prevent foreknowledge of treatment assignment, and thus shielded those who recruited participants from being influenced by this knowledge’
Blinding of participants and personnel	High risk	Quote: ‘The study was open labelled; neither the participants nor the researchers were blinded’.
Blinding of outcome assessment	Low risk	The allocation sequence was concealed from the researcher who enrolled and assessed the participants
Incomplete outcome data	Low risk	Missing data have been imputed using appropriate methods
Selective reporting	High risk	Shuttle walk test and EORTC data are reported incompletely
Other bias	Low risk	The study appears to be free of other sources of bias
Postoperative: Brocki et al. 8
Sequence generation	Low risk	Quote: ‘Computer-generated randomization tables, stratified for pneumonectomy (expected low performance status) were used’.
Allocation concealment	Low risk	Quote: ‘Individual allocations were placed in consecutively numbered and sealed opaque envelopes by an external person’
Blinding of participants and personnel	High risk	Open label
Blinding of outcome assessment	Low risk	Assessors were blinded to the patient’s group allocation
Incomplete outcome data	Low risk	Analyses were based on an intention-to-treat approach, assuming that each individual adhered to their assigned treatment at each time point
Selective reporting	Low risk	All pre-specified outcomes were reported
Other bias	Low risk	The study appears to be free of other sources of bias

FEV₁: forced expiratory volume in first second; DLCO: diffusing lung capacity of carbon monoxide; FVC: functional vital capacity; IG: intervention group; CG: control group; 6MWT: Six-Minute Walk Test; SF-36: Short Form 36; EORTC: European Organisation for Research and Treatment of Cancer.

Appendix 3

Results of the studies selected

Preoperative PR

Exercise capacity

Reference – exercise capacity	Assessment	IG			CG			p value IG-CG
		N	Mean ± SD	p value	N	Mean ± SD	p value
Stefanelli et al.37 – VO2 peak (mL/kg/min)	Baseline	NR	14.9 ± 2.3	<0.001	NR	14.8 ± 1.4	NS	NS
	Before surgery		17.8 ± 2.1			14.5 ± 1.2		<0.001
	60 days post-surgery		15.1 ± 2.4	<0.001 versus T1		11.4 ± 1.2	<0.001 versus T0 and T1	<0.01

IG: intervention group; CG: control group; SD: standard deviation; NS: not significant; NR: not reported.

Postoperative PR

Exercise capacity

Reference – exercise capacity		Assessment	IG				CG				Between-group difference (95% CI)	p value IG-CG
			N	Mean change from baseline ± SD	Mean ± SD	MD (95% CI)	N	Mean change from baseline ± SD	Mean ± SD	MD (95% CI)
Hoffman et al.27 – 6MWT		Baseline (before surgery)	37		365 ± 91	NR	35		407 ± 64	NR		0.03
		Post-study (6 weeks post-surgery)	37		+15% (SD, 15%)		35		−21% (SD, 19%)			<0.001
Cavalheri et al.25	VO2 peak (L/min)	Baseline (6–10 weeks post-surgery)	6		0.96 ± 0.22	0.14 (−0.01 to 0.28)	8		1.08 ± 0.40	−0.05 (−0.15 to 0.05)		NR
		8 weeks after baseline	6		1.96 ± 0.28		8		1.03 ± 0.30		0.2 (0.03 to 0.33)	0.02
	6MWT (m)	Baseline (6–10 weeks post-surgery)	6		540 ± 71	45 (6 to 83)	8		477 ± 78	−8 (−36 to 20)		NR
		8 weeks after baseline	6		585 ± 77		8		496 ± 105		52 (12 to 93)	0.02
Edvardsen et al.38 – VO2 peak (mL/kg/min)		Baseline (4–6 weeks post-surgery)	30		19.2 ± 5.1	NR	31		18.1 ± 5.5	NR	NR	NR
		After PR (20 weeks)	30		23.3 ± 5.5		31		19 ± 6		3.4 (1.3 to 5.5)	2
Brocki et al.8 – 6MWT (m)		Baseline (3 weeks post-surgery)	41	427a ± 124		NR	37	407a ± 102		NR	NR	NR
		4 months after baseline	32	+61 ± 52			34	+55 ± 45			8.33 (−20 to 36.27)	0.57
		1 year after baseline	27	+65 ± 70			29	+60 ± 45			1.31 (−28.18 to 30.8)	0.93
Arbane et al.39 – ISWT		Arbane et al. did not report exercise capacity levels measured by ISWT clearly

IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; 6MWT: Six-Minute Walk Test; ISWT: Incremental Shuttle Walk Test; NR: not reported.

^aMean.

HRQoL

SF-36

Physical domain	Reference	Assessment	IG			CG			Between-group difference (95% CI)	p value IG-CG
			N	Mean change ± SD	95% CI	N	Mean change ± SD	95% CI
Physical functioning	Arbane et al.39a	4 weeks post-surgery	40	9	−3.8 to 22	38	24	10.5 to 36.8	18 (3 to 32.4)	0.02
	Brocki et al.8	Baseline (3 weeks post-surgery)	41	60.37 ± 25		37	59.05 ± 23		NR	NR
		4 months after baseline	32	8.4 ± 21.3		35	6.4 ± 20.1		4.39 (−4 to 12.8)	0.3
		1 year after baseline	27	4.8 ± 24.3		31	14.5 ± 20.3		−4.87 (−13.7 to 4)	0.28
Role-physical	Arbane et al.39a	4 weeks post-surgery	40	32	6.7 to 56.9	38	43	13.8 to 72.8	24 (−3.8 to 52.7)	0.13
	Brocki et al.8	Baseline (3 weeks post-surgery)	41	31.7 ± 29		37	36.66 ± 24		NR	NR
		4 months after baseline	32	28.1 ± 33.8		35	15 ± 27.2		12.04 (−1 to 25.1)	0.07
		1 year after baseline	27	26.4 ± 42.3		31	34.9 ± 26		−6.93 (−20.7 to 6.99)	0.33
Bodily pain	Arbane et al.39a	4 weeks post-surgery	40	28	13.9 to 41.7	38	28	12.6 to 42.7	3 (−13.3 to 19.5)	0.69
	Brocki et al.8	Baseline (3 weeks post-surgery)	41	45.83 ± 28		37	45.51 ± 24		NR	NR
		4 months after baseline	32	30.3 ± 24.9		35	15.3 ± 34.2		15.3 (4 to 26.6)	0.01
		1 year after baseline	27	28.4 ± 24.5		31	30.8 ± 33.7		4.32 (−7.8 to 16.5)	0.49
General health	Arbane et al.39a	4 weeks post-surgery	40	7	0 to 13.6	38	1	−11.4 to 4.2	−4 (−16.6 to 9.6)	0.85
	Brocki et al.8	Baseline (3 weeks post-surgery)	41	68.32 ± 21		37	66.38 ± 19		NR	NR
		4 months after baseline	32	−1.88 ± 18.7		35	1.1 ± 12.9		−2.64 (−10.11 to 4.9)	0.49
		1 year after baseline	27	−2.81 ± 19		31	7.74 ± 15.3		−10.34 (−18.3 to −2.4)	0.01

IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; NR: not reported.

^aData refer to the subgroup with airflow obstruction.

Mental domain	Reference	Assessment	IG			CG			Between-group difference (95% CI)	p value IG-CG
			N	Mean change ± SD	95% CI	N	Mean change ± SD	95% CI
Vitality	Arbane et al.39a	4 weeks post-surgery	40	12	0 to 24.6	38	13	1.9 to 23.4	7 (−5.1 to 18.3)	0.26
	Brocki et al.8	Baseline (3 weeks post-surgery)	41	46.46 ± 18		37	43.24 ± 16		NR	NR
		4 months after baseline	32	15.94 ± 20		35	14.1 ± 15		4.65 (−2.98 to 12.3)	0.23
		1 year after baseline	27	12 ± 24.2		31	22.2 ± 15		−8.48 (−16.4 to −0.6)	0.04
Social functioning	Arbane et al.39a	4 weeks post-surgery	40	2	−17 to 21.5	38	10	−10 to 30	18 (−5.5 to 41)	0.13
	Brocki et al.8	Baseline (3 weeks post-surgery)	41	73.78 ± 27		37	73.65 ± 30		NR	NR
		4 months after baseline	32	13.3 ± 24.4		35	9.3 ± 31.9		3.7 (−5.8 to 13.2)	0.44
		1 year after baseline	27	14.81 ± 27.5		31	19.35 ± 26.8		−2.01 (−12 to 7.8)	0.67
Role-emotional	Arbane et al.39a	4 weeks post-surgery	40	3	−40.6 to 34.5	38	42	0.1 to 84.3	45 (−0.2 to 89.2)	0.05
	Brocki et al.8	Baseline (3 weeks post-surgery)	41	56.91 ± 36		37	53.6 ± 33		NR	NR
		4 months after baseline	32	12.5 ± 43.4		35	20.7 ± 31.5		−11.93 (−14 to 10.1)	0.75
		1 year after baseline	27	21 ± 41.4		31	36.81 ± 35		3.39 (−16.3 to 9.5)	0.61
Mental health	Arbane et al.39a	4 weeks post-surgery	40	−8	−15.5 to −0.5	38	2	−9.3 to 13.6	8 (−3.3 to 18.5)	0.16
	Brocki et al.8	Baseline (3 weeks post-surgery)	41	60.76 ± 18		37	60.97 ± 17		NR	NR
		4 months after baseline	32	9 ± 18.9		35	6.6 ± 19.3		3.77 (−2.7 to 110.2)	0.25
		1 year after baseline	27	7.6 ± 13.3		31	14.8 ± 16.2		−3.6 (−10.4 to 3.2)	0.3

IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; NR: not reported.

^aData refer to the subgroup with airflow obstruction.

EORTC

Arbane et al.³⁹ – ‘no significant differences were found between the groups using EORTC QLQ-LC13’.

Edvardsen et al.³⁸

	Assessment	IG			CG			p value IG-CG
		N	Mean	SD	N	Mean	SD
Dyspnoea	Baseline (4–6 weeks post-surgery)	30	33.3	NR	31	33.3	NR	NS
	After PR (20 weeks)	30	37	25.3	31	58	32.1	0.03

IG: intervention group; CG: control group; SD: standard deviation; CI: confidence interval; NR: not reported; NS: not significant; NR: not reported.